Cargando…
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours
OBJECTIVE: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) encompass a diverse group of neoplasms that vary in their secretory products and in their location within the gastrointestinal tract. Their prevalence in the USA is increasing among all adult age groups. AIM: To identify the possibl...
Autores principales: | Rico, Karen, Duan, Suzann, Pandey, Ritu L, Chen, Yuliang, Chakrabarti, Jayati T, Starr, Julie, Zavros, Yana, Else, Tobias, Katona, Bryson W, Metz, David C, Merchant, Juanita L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576490/ https://www.ncbi.nlm.nih.gov/pubmed/34750164 http://dx.doi.org/10.1136/bmjgast-2021-000765 |
Ejemplares similares
-
New Developments in the Treatment of Neuroendocrine Tumours – RADIANT-4, NETTER-1 and Telotristat Etiprate
por: Sbardella, Emilia, et al.
Publicado: (2016) -
Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019) -
Tumour ablation: technical aspects
por: Widmann, Gerlig, et al.
Publicado: (2009) -
Tumour ablation: current role in the kidney, lung and bone
por: Gillams, Alice
Publicado: (2009) -
2007 World Health Organization classification of tumours of the central nervous system
por: Thurnher, Majda M.
Publicado: (2009)